InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity
Autor: | Mark F. Naylor, Tomas Hode, Samuel S.K. Lam, Xiaosong Li, Robert E. Nordquist, Luciano Alleruzzo, Wei R. Chen, Feifan Zhou, Lei Shi, Xiuli Wang, Nan Du, Joseph Raker |
---|---|
Rok vydání: | 2015 |
Předmět: |
Cancer Research
medicine.medical_treatment Immunoadjuvant Article Immune system Adjuvants Immunologic Antigen Antigens Neoplasm Immunity Animals Humans Medicine Neoplasm Metastasis Antigen-presenting cell Antigen Presentation business.industry Mammary Neoplasms Experimental Photoimmunotherapy Immunotherapy Phototherapy Oncology Immunology Cancer research Female Cancer vaccine business |
Zdroj: | Cancer Letters. 359:169-177 |
ISSN: | 0304-3835 |
Popis: | A novel, promising potential cancer vaccine strategy was proposed to use a two-injection procedure for solid tumors to prompt the immune system to identify and systemically eliminate the primary and metastatic cancers. The two-injection procedure consists of local photothermal application on a selected tumor intended to liberate whole cell tumor antigens, followed by a local injection of an immunoadjuvant that consists of a semi-synthetic functionalized glucosamine polymer, N-dihydro-galacto-chitosan (GC), which is intended to activate antigen presenting cells and facilitate an increased uptake of tumor antigens. This strategy is thus proposed as an in situ autologous cancer vaccine (inCVAX) that may activate antigen presenting cells and expose them to tumor antigens in situ, with the intention of inducing a systemic tumor specific T-cell response. Here, the development of inCVAX for the treatment of metastatic cancers in the past decades are systematically reviewed. The antitumor immune responses of local photothermal treatment and immunological stimulation with GC are also discussed. This treatment approach is also commonly referred to as laser immunotherapy (LIT). |
Databáze: | OpenAIRE |
Externí odkaz: |